CMS certification 460010
Intermountain Medical Center
5121 South Cottonwood Street, Murray, UT 84107
Intermountain Medical Center has a CMS overall rating of 5 out of 5 stars. 78% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 9 and worse on none. Emergency patients spend a median of 3 h 38 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 1,383 completed surveys, 25% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | UT | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 449 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 38 min | 2 h 13 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 35 visits sampled | 3 h 57 min | 3 h 25 min | 4 h 17 min |
| Left before being seen Lower is better · 91,221 patients | 1% | 1% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 21 patients | 43% | 69% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 174 patients | 41% | 68% | 65% |
How Intermountain Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Intermountain Medical CenterThis hospital | 5/5 | 78% | 3 h 38 min | 9 better |
| Holy Cross Hospital - Salt LakeSame county · Salt Lake City | 3/5 | 66% | 2 h 26 min | 1 better |
| Intermountain Health Alta View HospitalSame county · Sandy | 5/5 | 80% | 3 h 2 min | 2 better |
| St Mark's HospitalSame county · Salt Lake City | 4/5 | 72% | 1 h 49 min | 5 better |
| Holy Cross Hospital-Jordan ValleySame county · West Jordan | 4/5 | 62% | 2 h 40 min | 3 better |
| University of Utah Hospital and ClinicsSame county · Salt Lake City | 5/5 | 83% | 3 h 54 min | 7 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 6,146 cases | Too few cases | 3.2% | 3.9% |
| Heart attack 306 cases | Too few cases | 9% | 11.9% |
| Heart failure 613 cases | Too few cases | 10.9% | 11.1% |
| Pneumonia 353 cases | Too few cases | 14.8% | 15.2% |
| Stroke 705 cases | Too few cases | 13.1% | 11.9% |
| COPD 69 cases | Too few cases | 7.7% | 8.6% |
| Heart bypass surgery (CABG) 84 cases | Too few cases | 2.1% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.86 likely 0.63 – 1.09 | 1 |
| Deaths after a serious but treatable surgical complication 185 cases | No different | 166.02 per 1,000 likely 125.43 per 1,000 – 206.62 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 7,132 cases | No different | 0.7 per 1,000 likely 0.2 per 1,000 – 1.19 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 8,688 cases | No different | 0.2 per 1,000 likely 0.02 per 1,000 – 0.38 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 9,038 cases | No different | 0.26 per 1,000 likely 0.07 per 1,000 – 0.44 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,938 cases | No different | 2.38 per 1,000 likely 1.18 per 1,000 – 3.57 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,281 cases | No different | 1.75 per 1,000 likely 0.56 per 1,000 – 2.94 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,300 cases | No different | 7.14 per 1,000 likely 2.82 per 1,000 – 11.46 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,287 cases | No different | 3.19 per 1,000 likely 1.59 per 1,000 – 4.79 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,387 cases | No different | 3.28 per 1,000 likely 0.68 per 1,000 – 5.88 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 847 cases | No different | 1.3 per 1,000 likely 0 per 1,000 – 2.62 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,129 cases | No different | 0.77 per 1,000 likely 0 per 1,000 – 1.6 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.5 likely 0.29 – 0.82 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.54 likely 0.32 – 0.85 | 1 |
| Surgical site infections after colon surgery | Better | 0.26 likely 0.07 – 0.7 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0 | 1 |
| MRSA bloodstream infections | No different | 0.67 likely 0.31 – 1.28 | 1 |
| C. diff intestinal infections | Better | 0.35 likely 0.24 – 0.48 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 551 cases | Too few cases | 11.7% | 14.4% |
| Readmitted after heart failure 1,150 cases | Too few cases | 18.1% | 21.3% |
| Readmitted after pneumonia 646 cases | Too few cases | 14.6% | 17.3% |
| Readmitted after COPD 157 cases | Too few cases | 19.6% | 20% |
| Readmitted after heart bypass surgery 118 cases | Too few cases | 11.5% | 11% |
| Days back in hospital after a heart attack 370 cases | Too few cases | -46 days per 100 | — |
| Days back in hospital after heart failure 697 cases | Too few cases | -63.9 days per 100 | — |
| Days back in hospital after pneumonia 365 cases | Too few cases | -48.4 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 1,438 cases | No different | 11.7 per 1,000 likely 9 per 1,000 – 15.3 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 206 cases | No different | 9 per 100 likely 6.5 per 100 – 12.4 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 206 cases | No different | 6.3 per 100 likely 4.3 per 100 – 9.1 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 770 cases | No different | 0.9 likely 0.7 – 1.2 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
638 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 21 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Physical Therapist | 53 |
| Occupational Therapist | 50 |
| Nurse Practitioner | 43 |
| Emergency Medicine | 42 |
| Anesthesiology | 40 |
| Physician Assistant | 39 |
| Hospitalist | 38 |
| Acute Care | 26 |
| Speech-Language Pathologist | 26 |
| Dietitian, Registered | 21 |
| Critical Care Medicine | 20 |
| Family | 20 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.9M
- 2020 $3.2M
- 2021 $2M
- 2022 $1.9M
- 2023 $1.8M
- 2024 $3.1M
- 2025 $2M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $47,960 | 1 |
| Grants | $29,129 | 4 |
| Space rental and facility fees | $25,900 | 10 |
| Consulting fees | $15,200 | 2 |
| Speaking, teaching and other services | $14,000 | 11 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Merck Sharp & Dohme LLC | $524,121 | 8 |
| Edwards Lifesciences Corporation | $398,869 | 79 |
| Abbvie INC. | $383,715 | 45 |
| Celgene Corporation | $138,222 | 5 |
| Amgen Inc. | $117,709 | 5 |
| Sumitomo Pharma America, Inc. | $60,204 | 6 |
| Pi-Cardia, Inc. | $52,600 | 1 |
| Procyrion, Inc. | $50,195 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Pos… Merck Sharp & Dohme LLC | $194,322 |
| An Open-Label Phase 1a,1b Dose-Escalation and Expansion Study Investigating the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of AB248 Alo… Merck Sharp & Dohme LLC | $158,400 |
| THE ENCIRCLE Trial (#2018-19) Edwards Lifesciences Corporation | $121,136 |
| A Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapil… Merck Sharp & Dohme LLC | $118,421 |
| A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 509 in Subjects With Metastatic Castration-Resistant Prost… Amgen Inc. | $108,221 |
| Edwards Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study 2017-19 Edwards Lifesciences Corporation | $96,996 |
| M20-638 - Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change … ABBVIE INC. | $86,788 |
| A Phase 2, Open-Label, Multicenter Study of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR T Cell Therapy in Adult Participants with Re… Celgene Corporation | $85,928 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Intermountain Medical Center
Is Intermountain Medical Center a good hospital?
Intermountain Medical Center has a CMS overall rating of 5 out of 5 stars. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 9 and worse on none. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Intermountain Medical Center?
78% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 1,383 completed HCAHPS surveys.
How long is the wait in the Intermountain Medical Center emergency room?
Emergency patients spend a median of 3 h 38 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Intermountain Medical Center receive money from drug and device companies?
Drug and device makers reported $2M in payments to Intermountain Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.